Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: A prospective cohort study

Clinical Infectious Diseases

Volumn 51, Issue 9, 2010, Pages 1007-1016

  Hung, Ivan F N ^a   Leung, Angela Y M ^a   Chu, Daniel W S ^b   Leung, Doris ^a   Cheung, Terence ^c   Chan, Chi Kuen ^a   Lam, Cindy L K ^a   Liu, Shao Haei ^b   Chu, Ng Ming ^d   Ho, Pak Leung ^a   Chan, Sophia ^a   Lam, Tai Hing ^a   Liang, Raymond ^a   Yuen, Kwok Yung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c DEPARTMENT OF HEALTH   (Hong Kong)

^d UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ACUTE HEART INFARCTION; AGED; AGED HOSPITAL PATIENT; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTPATIENT; PNEUMONIA; PRIORITY JOURNAL; STROKE; VACCINATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HONG KONG; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INTENSIVE CARE; MALE; MYOCARDIAL INFARCTION; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; STROKE; VACCINATION;

EID: 77958540519     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656587     Document Type: Article

References (40)

1. Ho PL, Que TL, Chiu SS, et al. Fluoroquiniolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg Infect Dis 2004; 10:1250-1257.
2. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009; 58:446-458.
3. Kahan NR, Waitman DA, Blackman S, et al. Suboptimal pneumococcal pneumonia vaccination rates among patients at risk in a managed care organization in Israel. J Manag Care Pharm 2006; 12:152-157.
4. Nichol KL. Influenza vaccination in the elderly: impact on hospitalization and mortality. Drugs Aging 2005; 22:495-515.
5. Nowalk MP, Zimmerman RK, Lin CJ, et al. Raising adult vaccination rates over 4 years among racially diverse patients at inner-city health centers. J Am Geriatr Soc 2008; 56:1177-1182.
6. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154:2666-2667.
7. Vila-Corcoles A, Ochoa-Gondar O, Hospital I, et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006; 43:860-868.
8. Ortqvist A, Hedlund J, Burman LA, et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Group. Lancet 1998; 351:399-403.
9. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348:1747-1755. (Pubitemid 36514705)
10. Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373-1381. (Pubitemid 47535592)
11. Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001; 357:1008-1111.
12. Hedlund J, Christenson B, Lundbergh P, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 2003; 21:3906-3911.
13. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17(suppl):S91-S93.
14. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-2618.
15. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10:83-92.
16. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007; 28:1205-1210.
17. Musher DM, Rueda AM, Kaka AS, et al. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007; 45:158-165.
18. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore) 2009; 88:154-159.
19. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among elderly. N Engl J Med 2003; 348:1322-1332. (Pubitemid 36384099)
20. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9:736-743.
21. Meyers DG. Myocardial infarction, stroke, and sudden cardiac deathmay be prevented by influenza vaccination. Curr Atheroscler Rep 2003; 5:146-149. (Pubitemid 38898866)
22. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102:3039-3045.
23. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33:513-518. (Pubitemid 34123398)
24. Lamontagne F, Garant MP, Carvalho JC, et al. Pneumococcal vaccination and risk of myocardial infarction. CMAJ 2008; 179:773-777.
25. The Government of the Hong Kong Special Administrative Region of the People's Republic of China. Healthy HK. http://www.healthyhk.gov.hk. Accessed 18 January 2010.
26. De Serres G, Lampron N, La Forge J, et al. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 2009; 46:129-133.
27. Nichol KL, Goodman M. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine 2002; 15(suppl 2):S21-S24.
28. Drummond M, Chevat C, Lothgren M. Do we fully understand the economic value of vaccines? Vaccine 2007; 25:5945-5957.
29. Rehm SJ, Farley MM, File TM Jr, et al. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med 2009; 121:101-105.
30. Schiller JS, Euler GL. Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. http://www.cdc.gov/nchs/data/ hestat/vaccine-coverage.pdf. Accessed 18 January 2010
31. Kohlhammer Y, Schnoor M, Schwartz M, et al. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health 2007; 121:742-751.
32. Lau JT, Yeung NC, Choi KC et al. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ 2009; 339:b4164.
33. Lau JT, Yeung NC, Choi KC et al. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine 2010; 28:4632-4637.
34. Slobodkin D, Kitlas J, Zielske P. Opportunities not missed-systematic influenza and pneumococcal immunization in a public inner-city emergency department. Vaccine 1998; 16:1795-1802.
35. Buxton J, Weatherill S, Hockin J, et al. Influenza and pneumococcal immunization 'blitz' in an inner city area: downtown eastside of Vancouver, British Columbia. Can Commun Dis Rep 2000; 26:117-122.
36. Siriwardena AN, Rashid A, Johnson MR, et al. Cluster randomized controlled trial of an educational outreach visit to improve influenza and pneumococcal immunization rates in primary care. Br J Gen Pract 2002; 52:735-740.
37. Vila-Corcoles A, Ochoa-Gondar O, Ester F, et al. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006; 18:231.
38. Yoo BK, Holland ML, Bhattacharya J, et al. Effects of mass media coverage on timing and annual receipt of influenza vaccination among medicare elderly. Health Serv Res 2010 [Epub ahead of print].
39. Honkanen PO, Keistinen T, Kivela SL. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997; 15:317-320.
40. Chou KL, Chi I. Factors associated with the use of publicly funded services by Hong Kong Chinese older adults. Soc Sci Med 2004; 58:1025-1035.